tirzepatide vs semaglutide study versus Once Weekly in Patients with Type 2 Diabetes Tirzepatide vs Semaglutide: Lower CV

The medication works by reducing appetite, slowing gastric emptying, and improving insulin sensitivity

Drinking water frequently and practicing oral hygiene is recommended

However, semaglutide (C), BPC-157 (C), and especially retatrutide (D) show inconsistent quality

Mounjaro is studied primarily for A1C, not body weight, but pivotal SURPASS trials in T2D patients showed average weight reductions of roughly 1520 lb at the 510 mg doses and up to 25 lb at 15 mg over 40 weeks

The most significant risk is hypoglycemia, especially for patients also taking insulin or sulfonylureas

The core difference between semaglutide and tirzepatide: how each drug works The most important difference between tirzepatide and semaglutide is their mechanism of action specifically, which hormone receptors they activate